el balón gástrico de Allurion, no es nada invasivo. Se trata de una pequeña cápsula, la cual es tragada por el paciente, y se introduce al estómago en donde a través de un pequeño catéter ...
El Balón Allurion, un balón gástrico no quirúrgico para la pérdida de peso, ha mostrado anteriormente resultados prometedores cuando se utiliza junto con los agonistas GLP-1. Un estudio ...
El Programa Allurion incluye un balón gástrico tragable, que forma parte de una plataforma más amplia para la pérdida de peso que también cuenta con atención virtual y un programa de cambio ...
Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated with GLP1 therapy, which the analyst calls ...
Company considering sites in France for clinical trial on combination therapy of Allurion Balloon and GLP-1s to prevent muscle loss Allurion Technologies, Inc. (“Allurion” or the “Company ...
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced ...
Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo. The data showed improved lean body mass and full ...
NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today ...
March 20, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced initial results on the combination ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback